Use of menopausal hormones in the United States, 1992 through June, 2003

Pharmacoepidemiology and Drug Safety
Diane K Wysowski, Laura A Governale

Abstract

The Women's Health Initiative (WHI) study that documented an unfavorable benefit to risk ratio of Prempro and subsequently an increased risk of stroke with menopausal estrogen prompted us to investigate the use during 1992 through June 2003 of menopausal hormones in the United States. Two pharmaceutical research databases from IMS Health, the National Prescription Audit Plus and the National Disease and Therapeutic Index, were accessed and analyzed. The number of dispensed outpatient prescriptions for oral menopausal estrogens and oral combination estrogen-progestins increased 2.5-fold (153%) from 34.5 million dispensed in 1992 to a high of 87.3 million in 2000. For July 2002 through June 2003, the year following the publication of the results of the WHI trial, prescriptions for these products declined to 59.6 million, a 32% decrease from their peak in 2000. Prescriptions for transdermal estrogen and transdermal combination estrogen-progestin products increased from 5.2 million dispensed in 1992 to their peak of 8.3 million in 2000, and declined 10% to 7.5 million during July 2002 through June 2003. By contrast, prescriptions for oral menopausal progestins rose to 17.5 million in 1995 and then steadily declined. In the year aft...Continue Reading

References

Sep 1, 1991·Archives of Internal Medicine·D K Wysowski, C Baum
Nov 1, 1988·American Journal of Public Health·E HemminkiS M McKinlay
Jan 1, 1995·Obstetrics and Gynecology·D K WysowskiL Burke
Apr 3, 1999·Annals of Internal Medicine·N L KeatingJ Z Ayanian
Mar 22, 2002·Journal of the American Academy of Dermatology·Diane K WysowskiAmarilys Vega
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Mar 19, 2003·The New England Journal of Medicine·Jennifer HaysUNKNOWN Women's Health Initiative Investigators
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Aug 9, 2003·The New England Journal of Medicine·John Bailar
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators

❮ Previous
Next ❯

Citations

Jul 10, 2007·Cancer Causes & Control : CCC·Christina A Clarke, Sally L Glaser
Dec 7, 2007·Chemical Research in Toxicology·Judy L Bolton, Gregory R J Thatcher
Oct 1, 2010·Menopause : the Journal of the North American Menopause Society·Daniel O StramGiske Ursin
May 24, 2007·Epilepsy Currents·Page B Pennell
Feb 12, 2010·American Journal of Public Health·Nancy KriegerPamela D Waterman
Jun 19, 2007·Drugs & Aging·Madhavi MallareddyWilliam B White
Mar 8, 2006·PharmacoEconomics·Diane K WysowskiJoslyn Swann
May 13, 2010·Journal of Women's Health·Euni LeeIlene H Zuckerman
Feb 12, 2009·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Elizabeth M KupfererHeather Becker
Jan 28, 2014·Obstetrics and Gynecology·John K ChanLaurel A Habel
Sep 10, 2014·Obstetrics and Gynecology·Patricia I JewettBrian L Sprague
Aug 26, 2006·Maturitas·Claire Z KalpakjianLoren L Toussaint
Jul 1, 2014·Menopause : the Journal of the North American Menopause Society·Jennifer CorbelliRachel Hess
Dec 21, 2006·Menopause : the Journal of the North American Menopause Society·Ira M HeleniusEthan A Halm
Feb 6, 2009·The Annals of Pharmacotherapy·Barbara G Silverman, Ehud S Kokia
Apr 24, 2019·Climacteric : the Journal of the International Menopause Society·R B NatariS A Hollingworth
Apr 11, 2013·Menopause : the Journal of the North American Menopause Society·Michelle P WarrenNancy L Sloan
Oct 26, 2018·Menopause : the Journal of the North American Menopause Society·Bruce EttingerMichael McBride
Jun 1, 2012·Menopause : the Journal of the North American Menopause Society·Jennifer A Corbelli, Rachel Hess
Dec 31, 2011·Menopause : the Journal of the North American Menopause Society·Bruce EttingerMichael McBride
Feb 24, 2018·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Sheldon Greenberg, Shannon Frattaroli
Apr 30, 2009·Behavioral Sciences & the Law·Simon A Cole
Mar 7, 2020·Menopause : the Journal of the North American Menopause Society·Macarius M DonneyongJoAnn E Manson
Jun 1, 2012·Menopause : the Journal of the North American Menopause Society·Amy R SteinkellnerSteven J Bowlin
Jul 26, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Andrea R GenazzaniEsme A Nijland
Dec 30, 2017·Menopause : the Journal of the North American Menopause Society·Joel L WeissfeldShelley R Slaughter
Nov 20, 2016·Pharmacoepidemiology and Drug Safety·Isabel Rosich MartíMaria Soler Cera
Sep 1, 2021·Journal of Mammary Gland Biology and Neoplasia·Anne GallezChristel Péqueux

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Adam L HershRandall S Stafford
Obstetrics and Gynecology
Diana S M BuistLarry Kessler
The New England Journal of Medicine
Peter M RavdinDonald A Berry
JAMA : the Journal of the American Medical Association
Jacques RossouwWriting Group for the Women's Health Initiative Investigators
© 2021 Meta ULC. All rights reserved